CADL EBITDA Growth
Candel Therapeutics Inc · EBITDA Growth
CADL EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-321.16%period ending
CADL TTM EBITDA YoY % (-145.10% → -321.16%)
Year-over-year change
High-resolution chart · PNG
CADL ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -321.1601% | |
| -36.5144% | |
| 32.3992% | |
| 57.5299% | |
| 57.4926% | |
| -9.158% | |
| -51.5152% | |
| -52.1673% | |
| -42.7399% | |
| -23.5115% | |
| -21.9637% | |
| -15.1288% | |
| 9.7556% | |
| 27.7408% | |
| 16.1651% | |
| 13.3944% | |
| -92.2925% | |
| -135.4062% | |
| -145.102% |